Specialty Pharmacy

Top news of the day from across the health care landscape.

A CRISPR gene-editing method has the ability to correct 3000 mutations that lead to Duchenne muscular dystrophy.

The CDC and the American Academy of Pediatrics released an updated vaccination schedule.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

FDA expands the indication of abiraterone acetate (Zytiga) to include more patients with prostate cancer.

Immunotherapy combination outperforms chemotherapy in patients with advanced or metastatic renal cell carcinoma.

Breast cancer survivors are more likely to die from heart disease than cancer.

Top news of the day from across the health care landscape.

New combination therapy gains approval for adult and pediatric patients with HIV-1.

Direct and indirect remuneration fees remain a top concern for pharmacists in 2018.

Reimbursement changes leave Arkansas pharmacies in jeopardy.

Ron Lanton III, Esq., President, True North Political Solutions, touches on some policies that are changing and may support biosimilar development.

Immunotherapy combination beneficial for patients with lung cancer with a high tumor mutation burden.

Evaluating medical and pharmacy benefits can provide a better view of a medication's value.

HIV may target CD4+ T cells that have a higher prevalence of a certain protein on their surfaces.

Top news of the day from across the health care landscape.

The genetic makeup of influenza may be able to determine how a strain will multiply.

Chronic HCV infection has been linked to low serum zinc and low metallothioneins expression in liver cells.

Thirty-five percent of drug approvals in 2017 were personalized drugs.

With more biosimilars poised to enter the market, stakeholders seek to ensure safety and efficacy.

The RAISE Family Caregivers Act aids individuals taking care of loved ones with chronic diseases.

Cutaneous T-cell lymphoma treatment may increase the risk of death among certain patients.

Top news of the day from across the health care landscape.

Ion channel inhibitors show promise reducing the high cost of conventional hepatitis C virus antiviral therapies.

Disease-modifying anti-rheumatic drugs are a major contributor to specialty drug spending.

The American College of Rheumatology said a recent Medicare rule may affect prescription drug access.

Brandon Newman, PharmD, CSP, Program Director, Vanderbilt Specialty Pharmacy, talks about why the Certified Specialty Pharmacist distinction is significant.

EB-101 is the only gene therapy that has received this designation for Epidermolysis Bullosa.